Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more from just $11.99/month.

Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?

UNLIMITED

Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?

FromOdd Lots


UNLIMITED

Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?

FromOdd Lots

ratings:
Length:
20 minutes
Released:
Nov 30, 2015
Format:
Podcast episode

Description

(Bloomberg) -- Hedge-fund manager Kyle Bass has a plan that could cut the high cost of prescription drugs in the U.S. -- and make himself a lot of money. The strategy: Take short positions in a number of pharmaceutical companies while also trying to overturn their drug patents in court. Joining hosts Tracy Alloway and Joe Weisenthal to discuss Bass's unusual tactic is Guan Yang, an occasional Bloomberg View contributor who has researched the odd intersection of Wall Street and patent law.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
Released:
Nov 30, 2015
Format:
Podcast episode

Titles in the series (100)

Bloomberg's Joe Weisenthal and Tracy Alloway analyze the weird patterns, the complex issues and the newest market crazes. Join the conversation every Monday and Thursday for interviews with the most interesting minds in finance, economics and markets.